Back to search

Article

Immunity response against mild-to-moderate breakthrough COVID-19

2022-05-31

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> The Omicron variant prevails the Delta variant after December 2021 in Thailand. Both variants of concern embody diverse epidemiological trends and immunogenicity, raising enormous public health concerns. We determined whether biological and clinical characteristics and immunogenicity of patients differ between Delta and Omicron during post-coronavirus disease 2019 (COVID-19) s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
972749c0-8d52-50c8-a391-8aa22cb985db
DOI
10.1101/2022.05.30.22275050
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunity response against mild-to-moderate breakthrough COVID-19DOI 10.1101/2022.05.30.22275050
Select a neighboring publication to make it the new centre.